A study of 166 women with suspicious mammograms who underwent ultrasound-guided fine-needle aspiration cytology (USFNAC) showed the technique to be 100% accurate in diagnosing cancers, reported Dr. Thomas G. Frazier at the annual meeting of the American Radium Society, held in Paris, France. This number is based on 3-month follow-up of the patients, said Dr. Frazier, who is Senior Attending Surgeon at the Bryn Mawr Hospital in Bryn Mawr, Pennsylvania,
"We found 17 early cancers in our study (none could be felt)," said Dr. Frazier, who is also Clinical Professor of Surgery at the Medical College of Pennsylvania. "In our study, the cost to diagnose each cancer was $4,667 when USFNAC was used. This compares to $52,505 per cancer diagnosed for standard biopsy procedures. That's more than a 91% savings," he commented.
"We looked at the costs of biopsy alone by averaging the costs of five patients and found that standard biopsies cost about $5,377. This compares to USFNAC, which costs only $478 per procedure," he said.